Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders: a brief report-Reference-Cited by-同舟云学术

Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders: a brief report

Published:2020-11-04 Issue:23 Volume:133 Page:2803-2807
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Xia Huan,Wang Yin,Sun Hua-Li,Gao Li-Ying,Cao Yu,Zaongo Silvere D.,Zeng Rong-Nan,Wu Hao,Zhang Ming-Jie,Ma Ping

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference14 articles.

1. Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: Challenges of immunological non-responders;Yang;J Leukoc Biol,2020

2. Skewed T-cell maturation and function in HIV-infected patients failing CD4+ recovery upon long-term virologically suppressive HAART;Marchetti;AIDS,2010

3. Regulatory T cells in HIV-infected immunological nonresponders are increased in blood but depleted in lymphoid tissue and predict immunological reconstitution;Gaardbo;J Acquir Immune Defic Syndr,2014

4. Cancer immunotherapy based on natural killer cells: current progress and new opportunities;Hu;Front Immunol,2019

5. Current progress in NK cell biology and NK cell-based cancer immunotherapy;Tarazona;Cancer Immunol Immunother,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-1/HBV Coinfection Accurate Multitarget Prediction Using a Graph Neural Network-Based Ensemble Predicting Model;International Journal of Molecular Sciences;2023-04-12

2. HIV Infection Predisposes to Increased Chances of HBV Infection: Current Understanding of the Mechanisms Favoring HBV Infection at Each Clinical Stage of HIV Infection;Frontiers in Immunology;2022-04-01